Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
26.69
-0.12 (-0.45%)
At close: Sep 14, 2026, 4:00 PM EDT
26.71
+0.02 (0.07%)
After-hours: Sep 14, 2026, 4:04 PM EDT
LKFT Market Cap
LKFT has a market cap or net worth of $1.75 billion as of September 14, 2026. Its market cap has decreased by -16.98% in one year.
Market Cap
1.75B
Enterprise Value
-825.42M
1-Year Change
-16.98%
Ranking
Category
Stock Price
$26.69
ChartMarket Cap Chart
Since May 14, 2015, LKFT's market cap has decreased from $1.86B to $1.75B, a decrease of -5.98%. That is a compound annual growth rate of -0.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 1.75B | -18.70% |
| Dec 31, 2025 | 2.15B | 18.91% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
| May 14, 2015 | 1.86B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemab Therapeutics Holdings | 1.84B |
| Xencor | 1.81B |
| Kailera Therapeutics | 1.81B |
| Septerna | 1.80B |
| Vir Biotechnology | 1.80B |
| Damora Therapeutics | 1.73B |
| Kardigan | 1.73B |
| Recursion Pharmaceuticals | 1.72B |